Concepedia

Author

David G. DeNardo

Washington University in St. LouisORCID

Also Known As

D G DeNardo, D. DeNardo, D. G. DeNardo, D.G. DeNARDO, D.G. DeNardo, D.G. Denardo, DAVID DENARDO, Daniel D. De Carvalho, David DeNardo, David Denardo

470

Publications

26.1K

Citations

62

H-Index

91

Concepts

All Affiliations

Washington University in St. LouisUniversity of California, San FranciscoJames S. McDonnell FoundationBaylor College of MedicineUCSF Helen Diller Family Comprehensive Cancer Center
DG

About

David G. DeNardo is an author at Washington University in St. Louis specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

28

39

7.8K

2

Engineering

3

3

131

3

Biomedical Engineering

3

3

131

4

Health Sciences

2

2

33

5

Allergy

1

1

82

David G. DeNardo

×

88

Publications

16.4K

Citations

51

H-Index

YearCitations

Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy

David G. DeNardo, Donal J. Brennan, Elton Rexhepaj,

Cancer Discovery

2011

1.7K

CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages

David G. DeNardo, Jairo Barreto, Pauline Andreu,

Cancer Cell

2009

1.3K

CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models

Yu Zhu, Brett L. Knolhoff, Melissa A. Meyer,

Cancer Research

2014

1.3K

Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy

Hong Jiang, Samarth Hegde, Brett L. Knolhoff,

Nature Medicine

2016

991

Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses

Jonathan B. Mitchem, Donal J. Brennan, Brett L. Knolhoff,

Cancer Research

2012

929

Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression

Yu Zhu, John M. Herndon, Dorothy K. Sojka,

Immunity

2017

764

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

Timothy M. Nywening, Andrea Wang‐Gillam, Dominic E. Sanford,

The Lancet Oncology

2016

746

Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression

Andrew L. Doedens, Christian Stockmann, Mark P. Rubinstein,

Cancer Research

2010

616

Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis

Dominic E. Sanford, Brian A. Belt, Roheena Z. Panni,

Clinical Cancer Research

2013

597

FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis

Pauline Andreu, Magnus Johansson, Nesrine I. Affara,

Cancer Cell

2010

565

Page 1